A comprehensive view of Liver/Kidney/Bladder Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves GSKs oral Jesduvroq daprodustat to treat anemia caused by chronic kidney disease in adults who have received dialysis for at least four months; CKD affect about 700 million patients worldwide, with one in seven developing anemia
Published: February 03, 2023 by GSK Group (GlaxoSmithKline)
Miromatrix and Baxter partner to advance care for patients with acute liver failure using Micromatrix’s miroliverELAP system; the system combines a Micromatrix single-use bioengineered liver connected to Baxter’s PriMax system outside patient's body
Published: February 01, 2023 by Baxter International Inc.
DaVita lists highlights from 2022, including referring over 92,000 patients for kidney transplants, with 7,800 patients receiving transplant, its highest number of annual transplants ever; record-setting 31,300 people participated in Kidney Smart class
Published: January 31, 2023 by DaVita Inc.
Eli Lilly, Boehringer Ingelheim announce FDA accepts sNDA for Jardiance empagliflozin, which is being investigated as a treatment to reduce risk of kidney disease progression, cardiovascular death in adults with chronic kidney disease
Published: January 20, 2023 by Eli Lilly & Co.
Bayer revises peak sales forecast for growth drivers in its pharma portfolio; peak sales projected to be over €12.0B, including projected sales of €3.0B for Nubeqa darolutamide prostate cancer drug, €3.0B in sales of Kerendia finerenone kidney drug
Published: January 11, 2023 by SeeNews Pharmaceuticals

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count